Research and analysis

Alkyl nitrites: ACMD exemption consideration

The Advisory Council on the Misuse of Drugs has provided an updated harms assessment of alkyl nitrites.

From:
Advisory Council on the Misuse of Drugs
Published
8 May 2024
Last updated
9 August 2024 鈥� See all updates

Documents

Alkyl nitrites: ACMD exemption consideration (accessible)

HTML

PDF, 620 KB, 51 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Alkyl nitrites: ACMD exemption consideration cover letter (accessible)

HTML

PDF, 188 KB, 5 pages

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email [email protected]. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

In August 2020 the government commissioned the Advisory Council on the Misuse of Drugs (ACMD) to give advice on exempting alkyl nitrites, known as 鈥榩oppers鈥� from the Psychoactive Substances Act (PSA) 2016.

This report summarises, expands and updates the already existing evidence on use and harms.

The ACMD recommends that alkyl nitrites should be exempted from the Psychoactive Substances Act 2016.

Updates to this page

Published 8 May 2024
Last updated 9 August 2024 show all updates

  1. Updated a reference to research by Measham, McCormack, Simmons and Wignall after it was accepted for publication. Added accessible versions of the documents.

  2. First published.

Sign up for emails or print this page